Clinical Trials
All Clinical Trials - Page 48 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT02374632Phase 4Unknown
Gut Hormones as Mediators of Different Weight Loss Responses After Roux-en-Y Gastric Bypass
Octreotide
- NCT02493517Phase 3Completed
Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly
Lanreotide
- NCT02231762Phase 2Completed
Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET
Lanreotide
- NCT03167320N/AUnknown
Low Von Willebrand in Ireland Cohort Study
Desmopressin
- NCT02291679Phase 3Completed
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
Linaclotide
- NCT02249871Phase 1Completed
Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
Semaglutide
- NCT02217566Phase 2Completed
Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy
Gonadorelin
- NCT02127437Phase 3Completed
Lanreotide In Polycystic Kidney Disease Study
Lanreotide
- NCT02243098Phase 1Completed
Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects
Semaglutide
- NCT02229383Phase 3Completed
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
Exenatide
- NCT02235961Phase 1Completed
Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects
Liraglutide
- NCT02229396Phase 3Completed
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
Exenatide
- NCT03353948Phase 4Completed
The Effect of a Liraglutide on IVF in Obese PCOS
Liraglutide
- NCT02231684Phase 1Completed
Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of Semaglutide
Semaglutide
- NCT02234089N/ACompleted
Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists.
Gonadorelin
- NCT02194595Phase 3Completed
Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
Exenatide
- NCT02417142Phase 4Completed
Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia
Exenatide
- NCT02276196Phase 4Completed
Effect of LIXIsenatide on the Renal System
Lixisenatide
- NCT02237053Phase 1Completed
Effects of Glucagon Administration on Energy Expenditure
Octreotide
- NCT02239510N/ATerminated
Efficacy of Linaclotide to Senna for CIC
Linaclotide
- NCT02205528Phase 2Completed
A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
Liraglutide
- NCT02212067Phase 1Completed
A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes
Semaglutide
- NCT03315325Phase 3Completed
Age-dependent Changes in the Responsiveness of Hypothalamic Pituitary Gonadal Axis in Men
Kisspeptin
- NCT02207374Phase 3Completed
A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes
Semaglutide
- NCT02282501Phase 4Completed
Leptin and Ghrelin in ICU
Ghrp-6
- NCT01933022Phase 4Terminated
A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the Disease
Gonadorelin
- NCT02207348Phase 1Completed
Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectors
Liraglutide
- NCT02147925Phase 4Completed
Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects
Liraglutide
- NCT02118376N/AUnknown
Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status
Exenatide
- NCT02157974Phase 2/Phase 3Completed
Liver and Fat Regulation in Overweight Adolescent Girls
Exenatide
- NCT02200991Phase 4Completed
Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine
Lixisenatide
- NCT02176382Phase 4Completed
Denosumab and Teriparatide Study (DATA-HD and DATA-EX)
Teriparatide
- NCT02020499N/ATerminated
Predictive Factors Study
Lanreotide
- NCT02220348Phase 1Completed
A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically
Linaclotide
- NCT04281680N/ACompleted
Impact of Pasireotide on Postoperative Pancreatic Fistulas Following Distal Resections
Octreotide
- NCT02388464Phase 1Completed
A Study Investigating the Safety, Tolerability, and Pharmacokinetics of MTP-131 in Subjects With Congestive Heart Failure
Elamipretide
- NCT01894581N/ACompleted
Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women
Gonadorelin
- NCT02152228Phase 2Completed
A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism
Teriparatide
- NCT02195635Phase 1Completed
Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects
Octreotide
- NCT03286517Phase 3Completed
Link Between the Sensitivity of Kisspeptin Signalling and Pubertal Onset in Boys.
Kisspeptin
- NCT02177773Phase 1/Phase 2Terminated
GA-68 DOTA-TOC of Somatostatin Positive Malignancies
Octreotide
- NCT01990040N/AActive Not Recruiting
Registry for Participants With Short Bowel Syndrome
Teduglutide
- NCT02168062Phase 2Terminated
Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer
Gonadorelin
- NCT04525157Phase 2Completed
Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV)
Afamelanotide
- NCT02172313Phase 1Completed
Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
Semaglutide
- NCT02161588Phase 1Completed
A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian Subjects
Semaglutide
- NCT02059213Phase 2Completed
A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer
Gonadorelin
- NCT02820415N/ACompleted
PGS on Blastocysts From Vitrified and Fresh Oocytes
Gonadorelin
- NCT01763541EARLY_Phase 1Withdrawn
Study of the Effect of Testosterone and Estradiol on NP Responses to Acute and Chronic Salt Loading
Gonadorelin
- NCT02784457Phase 2Completed
Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome
Gonadorelin